Ra Capital Management, L.P. - Director, 10%+ Owner at Tyra Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
TYRA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ra Capital Management, L.P. since 7/14/2023

Holdings reported by Ra Capital Management, L.P. for Tyra Biosciences, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 8.48 M $110 M $13.01 Feb 6, 2024 Indirect
Pre-Funded Warrants (Right to Buy) 1.54 M $20 M $13.01 Feb 6, 2024 Indirect Common Stock
Stock Option (right to buy) 18.6 K May 29, 2024 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Tyra Biosciences, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership